AFFINITY CHROMATOGRAPHY MATRIX
First Claim
1. An affinity chromatography matrix, in form of a gel, comprising polymeric particles on which at least one oligosaccharide corresponding to a blood group A and/or group B epitope is grafted, said oligosaccharide being grafted to said particles via a spacer, wherein the density of oligosaccharides is comprised between 0.2 and 0.7 mg/ml of matrix and said spacer has a formula (I) —
- NH—
R1-CO—
NH—
R2-, wherein R1 is a C4-C6 alkyl group, R2 is a C3-C8 alkyl group, and said spacer is bound through its amine function to the particle.
3 Assignments
0 Petitions
Accused Products
Abstract
The invention relates to an affinity chromatography matrix, as a gel, comprising polymeric particles on which at least one oligosaccharide corresponding to a blood group A epitope and/or blood group B is grafted, via a spacer, characterized in that the density of oligosaccharides is comprised between 0.2 and 0.7 mg/ml of matrix. The invention also relates to the uses of this matrix for preparing concentrates of immunoglobulins for therapeutic use.
-
Citations
19 Claims
-
1. An affinity chromatography matrix, in form of a gel, comprising polymeric particles on which at least one oligosaccharide corresponding to a blood group A and/or group B epitope is grafted, said oligosaccharide being grafted to said particles via a spacer, wherein the density of oligosaccharides is comprised between 0.2 and 0.7 mg/ml of matrix and said spacer has a formula (I) —
- NH—
R1-CO—
NH—
R2-, wherein R1 is a C4-C6 alkyl group, R2 is a C3-C8 alkyl group, and said spacer is bound through its amine function to the particle. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19)
- NH—
Specification